American Century Companies’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.4M | Sell |
351,052
-236,002
| -40% | -$7.67M | 0.01% | 1320 |
|
2025
Q1 | $22.2M | Sell |
587,054
-18,213
| -3% | -$688K | 0.01% | 995 |
|
2024
Q4 | $49.5M | Buy |
605,267
+76,262
| +14% | +$6.24M | 0.03% | 628 |
|
2024
Q3 | $60.4M | Buy |
529,005
+1,411
| +0.3% | +$161K | 0.04% | 527 |
|
2024
Q2 | $39.8M | Buy |
527,594
+65,870
| +14% | +$4.97M | 0.02% | 660 |
|
2024
Q1 | $31.5M | Buy |
461,724
+54,495
| +13% | +$3.72M | 0.02% | 740 |
|
2023
Q4 | $25.6M | Buy |
407,229
+35,487
| +10% | +$2.23M | 0.02% | 777 |
|
2023
Q3 | $19M | Buy |
371,742
+9,099
| +3% | +$464K | 0.01% | 823 |
|
2023
Q2 | $18.1M | Buy |
+362,643
| New | +$18.1M | 0.01% | 818 |
|
2023
Q1 | – | Sell |
-8,062
| Closed | -$387K | – | 2686 |
|
2022
Q4 | $387K | Buy |
+8,062
| New | +$387K | ﹤0.01% | 2136 |
|